Developer docs
API playgroundTry for free, no card

Search company profiles

RxAnte

Full company profile

uuid0000zv3

Namestring
RxAnte
Legal namestring
RxAnte, Inc.
Websiteurl
rxante.com
Company typeenum
Private
Founded yearint
2011
Descriptiontext

RxAnte is a Portland, Maine-based healthcare technology company founded in 2011 that builds predictive analytics and clinical workflow software to improve medication prescribing and adherence, primarily for U.S. health plans serving Medicare Advantage, Medicaid, and Commercial populations. The platform combines three patented technology layers: RxAnte Core Analytics/RxAnte Score (member-level adherence and unsafe-use risk scoring protected by U.S. Patent 11,244,029), Value of Future Adherence predictive models (protected by four additional patents including 10,318,897 and 11,887,027), and RxEffect, a clinical workflow solution for pharmacists, care managers, and community-based providers (protected by four patents including 10,108,975 and 12,327,262). The company operates its technology-enabled pharmacy care management subsidiary, Mosaic Pharmacy Service, as a value-based pharmacy service for medically complex and vulnerable Medicare beneficiaries, managing over 34 million lives as of 2026.

RxAnte generates revenue through subscription analytics services (population-level reporting and member-level predictions delivered on a recurring basis), value-based pharmacy services via Mosaic, performance-based contracts that use real-world evidence to support value-based agreements between health plans and pharma manufacturers, and clinical intervention programs. Pricing is enterprise-negotiated and not publicly disclosed. Go-to-market is direct enterprise field sales targeting health plan C-suite, pharmacy directors, and quality executives, with a curated network of patient engagement vendors and provider network partnerships (RxEffect) extending reach to mid-market providers.

The company has accumulated roughly $44.6 million+ in disclosed institutional capital across rounds from Aberdare Ventures, West Health Investment Fund, UPMC Enterprises, Trinity Capital, and Primus Capital, with Primus Capital's January 2026 strategic growth investment the most recent signal of institutional confidence. Notable commercial partners include UPMC Health Plan (customer since 2013, equity partner since 2016), Geisinger Health Plan, AvMed, Horizon Healthcare Services, EnvisionInsurance, WellCare Health Plans, and Aetna. The company is HITRUST CSF Certified and SOC 2 Type II certified, both prerequisites for handling protected health information at health-plan scale.

Short descriptiontext

RxAnte provides patented predictive analytics and clinical workflow technology to U.S. health plans for improving medication adherence, pharmacy quality, and total cost of care. Its RxEffect tool, RxAnte Score models, and Mosaic Pharmacy Service subsidiary serve Medicare Advantage, Medicaid, and commercial plans managing 34M+ lives.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersPortland, United States
HQ citystring
Portland
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medication adherence analytics, pharmacy care management, predictive health analytics, value-based pharmacy services, population health management
Industry4 codes
PRIMARYHLAEAKAK
Pharmacy Benefit Analytics, Reporting & Employer Consulting
SECONDARYHLAEAKAL
PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools)
SECONDARYHLACAKAH
Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYBPAHALAN
Healthcare Outcomes & Real-World Evidence (RWE) Analytics
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Pharmacy Care Management Analytics
Social media profiles2 records
Revenue model4 records
1Subscription Analytics Services
TypeSubscription Recurring
Description

Population-level reporting, forecasts, and member-level predictions delivered on a subscription basis to inform medication adherence and intervention strategies for chronic illness medications.

2Value-Based Pharmacy Services (Mosaic Pharmacy Service)
TypeSubscription Recurring
Description

High-touch, data-driven pharmacy care management services for medically complex and vulnerable Medicare populations. Delivered as a technology-enabled pharmacy care management subsidiary.

rxante.com
3Performance-Based Contracts
TypeUsage Based
Description

Value-based arrangements where RxAnte facilitates collection and analysis of real-world evidence to inform value-based contracts between health plans and pharmaceutical manufacturers.

rxante.com
4Clinical Intervention Programs
TypeSubscription Recurring
Description

Targeted patient-engagement programs, provider engagement, and direct-to-member interventions as part of turnkey adherence improvement programs.

rxante.com
Marketing channels11 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Mosaic Pharmacy Service
Description

A technology-enabled pharmacy care management subsidiary that provides high-touch, data-driven pharmacy care for medically complex and vulnerable populations, managing care for over 34 million lives across U.S. health plans as of 2026.

rxante.com
Core offering1 text field

RxAnte builds patented predictive analytics software (RxAnte Core Analytics/RxAnte Score, Value of Future Adherence) that uses pharmacy and medical claims data to forecast medication adherence and identify at-risk members. Its RxEffect workflow solution operationalizes these predictions for pharmacists, care managers, and providers, while the Mosaic Pharmacy Service subsidiary delivers in-home, value-based pharmacy care to medically complex Medicare beneficiaries. Customers are enterprise health plans, Medicaid plans, and value-based provider organizations.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • $406 PMPM savings; 32% reduction in inpatient stays
+6 more records
Product overview1 text field

RxAnte is a health technology company offering a platform-plus-modules architecture for pharmacy care management. The core RxAnte Core Analytics / RxAnte Score platform provides patented predictive analytics for medication adherence risk assessment and member prioritization. RxEffect serves as the clinical workflow and adherence workflow solution for care managers and pharmacists. Mosaic Pharmacy Service is a technology-enabled subsidiary delivering high-touch pharmacy care for medically complex Medicare populations. The platform also includes specialized products like Value of Future Adherence (VFA) and Risk of Unsafe Use Score for opioid risk identification. The system combines advanced data science with practical clinical application to help health plans achieve measurable improvements in quality of care, total cost of care, and member experience.

Product and service3 records
1RxAnte Core Analytics / RxAnte Score
CategoryPredictive Analytics Platform
Description

Patented predictive analytics platform that uses pharmacy and medical claims data to assess risk of unsafe medication use, predict future medication adherence at the member level, and generate risk scores to prioritize outreach. Sold to enterprise health plans, Medicaid plans, and value-based providers.

2RxEffect Adherence Workflow Solution
CategoryClinical Workflow Software
Description

Clinical workflow and decision-support platform for pharmacists, care managers, and community-based providers that translates RxAnte's predictive analytics into configurable adherence workflows, weekly management reporting, and targeted patient-engagement program delivery. Sold to health plans and the providers serving their members.

3Mosaic Pharmacy Service
CategoryValue-Based Pharmacy Care Service
Description

Technology-enabled, value-based pharmacy care management service delivered by RxAnte's wholly-owned subsidiary to medically complex and vulnerable Medicare populations, providing high-touch, data-driven in-home pharmacy care to reduce hospitalizations and total cost of care. Sold directly to enterprise health plans.

Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierSignificantTypeStrategic or Co-development PartnerAnnounced on2019-02-04
Description

Partnership announced February 2019. RxAnte delivers population-level analytics and member-level decision support to inform Geisinger's pharmacy quality strategy, focusing on members' adherence to diabetes, hypertension, and high cholesterol medications.

Strategic tierMinorTypeImplementation/ SI/ Consulting PartnerAnnounced on2019-02-04
Description

Coalfire served as the HITRUST CSF Assessor conducting a thorough review of RxAnte's policies and practices during the HITRUST CSF certification process, focusing on oversight of the organization, vendor management programs, internal corporate governance, and risk management processes.

3EnvisionInsurance
Strategic tierSignificantTypeStrategic or Co-development PartnerAnnounced on2016-07-19
Description

Partnership continued July 2016. RxAnte uses data from large patient populations to predict individual patient adherence and develops customized interventions and outreach programs for each member, improving health outcomes and controlling costs for EnvisionInsurance's Part D members.

4Horizon Healthcare Services, Inc.
Strategic tierSignificantTypeStrategic or Co-development PartnerAnnounced on2016-05-16
Description

Renewed collaboration in May 2016. RxAnte provides advanced analytics solutions to predict future outcomes and manage prescription medication use for Horizon's Medicare Advantage population. Focus on triple-weighted Star Ratings medication adherence measures.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2016-01-01
Description

UPMC Health Plan has been a partner since 2016, collaborating on peer-reviewed outcomes studies demonstrating Mosaic's effectiveness in improving health outcomes and reducing medical costs. UPMC also established a Center for Value-Based Purchasing for Pharmaceuticals in partnership with RxAnte. Brent Burns, EVP of UPMC Enterprises, stated Primus partnership will help accelerate bringing RxAnte solutions to more patients.

Strategic tierSignificantTypeStrategic or Co-development PartnerAnnounced on2015-11-03
Description

Partnership announced November 2015. RxAnte's advanced analytics platform delivered population-level reporting and member-level predictions to inform AvMed's adherence and intervention strategy for medications used to treat chronic illnesses for the Medicare Advantage Part D population.

Strategic tierSignificantTypeStrategic or Co-development PartnerAnnounced on2015-01-01
Description

RxAnte collaborated with PQA, Aetna, and WellCare to devise new performance measures to address opioid misuse/abuse. PQA endorsed these new opioid quality measures, which unsafe opioid use leads to nearly 100,000 ER visits annually.

Strategic tierSignificantTypeStrategic or Co-development PartnerAnnounced on2014-01-16
Description

Agreement entered January 2014. RxAnte's advanced analytics platform used to identify existing Medicare members eligible for WellCare's Medication Therapy Management (MTM) services. WellCare has been providing MTM services since 2006 and working with RxAnte on medication quality measures since 2012.

Strategic tierSignificantTypeStrategic or Co-development PartnerAnnounced on2013-01-01
Description

Innovative program launched in 2013 to engage providers in improving medication adherence for patients predicted to be at high risk. Co-hosted webinar between Aetna VP of Star Ratings and RxAnte senior leadership on pay-for-performance programs and medication adherence.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AllazoHealth is an AI-driven medication adherence prediction platform serving health plans and PBMs. It is the closest functional peer to RxAnte, using predictive analytics on claims data to target adherence interventions for similar payer customers.

TypeDirect peer
Description

AdhereHealth provides medication adherence analytics and pharmacy care management services to Medicare Advantage, Medicaid, and commercial health plans. It overlaps directly with RxAnte's core analytics + intervention model and shares the same payer customer base.

TypeDirect peer
Description

OptimizeRx operates a digital therapeutics and adherence platform targeting prescribers and patients, with a network reaching the majority of US prescribers. It is comparable to RxAnte in addressing medication adherence through data-driven, point-of-care engagement with overlapping payer and pharma customers.

TypeDirect peer
Description

mPulse Mobile delivers conversational AI-driven patient engagement programs for medication adherence, condition management, and health plan quality measures. It serves many of the same MA and Medicaid plans as RxAnte, executing the patient-engagement layer that RxAnte's RxEffect orchestrates.

TypeDirect peer
Description

Medisafe is a digital medication adherence platform combining a consumer app, predictive analytics, and payer integrations. It targets a similar problem space as RxAnte (medication non-adherence in chronic disease) but with more consumer-direct positioning, making it a partial-overlap peer.

TypeDirect peer
Description

emocha Health provides a medication adherence platform with directly observed therapy and asynchronous video verification, increasingly used by health plans for MTM and Star Ratings programs. It overlaps with RxAnte's clinical workflow and MTM focus areas.

7Pack4U (Tabula Rasa HealthCare / CarelonRx)
TypeEmerging player
Description

Pack4U delivers in-home and tech-enabled pharmacy services for complex patients, closely mirroring RxAnte's Mosaic Pharmacy Service value-based model. Both target medically complex Medicare populations with high-touch pharmacy care, though Pack4U is at an earlier commercial scale.

TypeBroad incumbent
Description

DrFirst provides ePrescribing, medication management, and clinical messaging across a large healthcare provider network. While broader in scope than RxAnte, its medication history, benefit, and adherence tooling overlaps with RxEffect and serves some of the same payer-provider ecosystem.

TypeBroad incumbent
Description

Surescripts operates the dominant US pharmacy electronic prescribing network and increasingly offers clinical and adherence-related intelligence to payers and providers. It is a broader infrastructure incumbent in the prescription data flow that RxAnte's analytics are built on.

TypeBroad incumbent
Description

CVS Caremark is one of the largest US PBMs with in-house adherence analytics, MTM programs, and value-based pharmacy initiatives. While not a direct SaaS competitor, it represents the vertically integrated incumbent that may build or buy capabilities competitive with RxAnte.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RxAnte

Pharmacy Care Management Analyticsrxante.com

RxAnte provides patented predictive analytics and clinical workflow technology to U.S. health plans for improving medication adherence, pharmacy quality, and total cost of care. Its RxEffect tool, RxAnte Score models, and Mosaic Pharmacy Service subsidiary serve Medicare Advantage, Medicaid, and commercial plans managing 34M+ lives.

What RxAnte does

RxAnte is a Portland, Maine-based healthcare technology company founded in 2011 that builds predictive analytics and clinical workflow software to improve medication prescribing and adherence, primarily for U.S. health plans serving Medicare Advantage, Medicaid, and Commercial populations. The platform combines three patented technology layers: RxAnte Core Analytics/RxAnte Score (member-level adherence and unsafe-use risk scoring protected by U.S. Patent 11,244,029), Value of Future Adherence predictive models (protected by four additional patents including 10,318,897 and 11,887,027), and RxEffect, a clinical workflow solution for pharmacists, care managers, and community-based providers (protected by four patents including 10,108,975 and 12,327,262). The company operates its technology-enabled pharmacy care management subsidiary, Mosaic Pharmacy Service, as a value-based pharmacy service for medically complex and vulnerable Medicare beneficiaries, managing over 34 million lives as of 2026.

RxAnte generates revenue through subscription analytics services (population-level reporting and member-level predictions delivered on a recurring basis), value-based pharmacy services via Mosaic, performance-based contracts that use real-world evidence to support value-based agreements between health plans and pharma manufacturers, and clinical intervention programs. Pricing is enterprise-negotiated and not publicly disclosed. Go-to-market is direct enterprise field sales targeting health plan C-suite, pharmacy directors, and quality executives, with a curated network of patient engagement vendors and provider network partnerships (RxEffect) extending reach to mid-market providers.

The company has accumulated roughly $44.6 million+ in disclosed institutional capital across rounds from Aberdare Ventures, West Health Investment Fund, UPMC Enterprises, Trinity Capital, and Primus Capital, with Primus Capital's January 2026 strategic growth investment the most recent signal of institutional confidence. Notable commercial partners include UPMC Health Plan (customer since 2013, equity partner since 2016), Geisinger Health Plan, AvMed, Horizon Healthcare Services, EnvisionInsurance, WellCare Health Plans, and Aetna. The company is HITRUST CSF Certified and SOC 2 Type II certified, both prerequisites for handling protected health information at health-plan scale.

RxAnte firmographics

Firmographics
Name
RxAnte
Legal name
RxAnte, Inc.
Website
https://rxante.com
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
51–100 employees
Short description
RxAnte provides patented predictive analytics and clinical workflow technology to U.S. health plans for improving medication adherence, pharmacy quality, and total cost of care. Its RxEffect tool, RxAnte Score models, and Mosaic Pharmacy Service subsidiary serve Medicare Advantage, Medicaid, and commercial plans managing 34M+ lives.
Ownership category
akta.pro rank

RxAnte industry classification

Industry
Product category
Pharmacy Care Management Analytics
NAICS
Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLAEAKAK
Pharmacy Benefit Analytics, Reporting & Employer Consulting
SECONDARYHLAEAKAL
PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools)
SECONDARYHLACAKAH
Medication Therapy Management (MTM) & Clinical Pharmacy Services Tools
Healthcare & Life Sciences/Digital Health & Health IT/ePrescribing, Medication Management & Pharmacy IT
SECONDARYBPAHALAN
Healthcare Outcomes & Real-World Evidence (RWE) Analytics

Keywords

  • Medication adherence analytics
  • Pharmacy care management
  • Predictive health analytics
  • Value-based pharmacy services
  • Population health management

Where RxAnte is headquartered

Location

Headquarters

HQ city
Portland
HQ country
United States
HQ region
North America

Offices3 records

Markets served

RxAnte business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Subscription Analytics Services: Population-level reporting, forecasts, and member-level predictions delivered on a subscription basis to inform medication adherence and intervention strategies for chronic illness medications.
  2. Value-Based Pharmacy Services (Mosaic Pharmacy Service): High-touch, data-driven pharmacy care management services for medically complex and vulnerable Medicare populations. Delivered as a technology-enabled pharmacy care management subsidiary.
  3. Performance-Based Contracts: Value-based arrangements where RxAnte facilitates collection and analysis of real-world evidence to inform value-based contracts between health plans and pharmaceutical manufacturers.
  4. Clinical Intervention Programs: Targeted patient-engagement programs, provider engagement, and direct-to-member interventions as part of turnkey adherence improvement programs.

Distribution channels3 records

Marketing channels11 records

RxAnte product offering

Product offering

Core offering

RxAnte builds patented predictive analytics software (RxAnte Core Analytics/RxAnte Score, Value of Future Adherence) that uses pharmacy and medical claims data to forecast medication adherence and identify at-risk members. Its RxEffect workflow solution operationalizes these predictions for pharmacists, care managers, and providers, while the Mosaic Pharmacy Service subsidiary delivers in-home, value-based pharmacy care to medically complex Medicare beneficiaries. Customers are enterprise health plans, Medicaid plans, and value-based provider organizations.

Product overview

RxAnte is a health technology company offering a platform-plus-modules architecture for pharmacy care management. The core RxAnte Core Analytics / RxAnte Score platform provides patented predictive analytics for medication adherence risk assessment and member prioritization. RxEffect serves as the clinical workflow and adherence workflow solution for care managers and pharmacists. Mosaic Pharmacy Service is a technology-enabled subsidiary delivering high-touch pharmacy care for medically complex Medicare populations. The platform also includes specialized products like Value of Future Adherence (VFA) and Risk of Unsafe Use Score for opioid risk identification. The system combines advanced data science with practical clinical application to help health plans achieve measurable improvements in quality of care, total cost of care, and member experience.

Differentiator

Problem solved

Functional benefit

Brands

  • Mosaic Pharmacy Service: A technology-enabled pharmacy care management subsidiary that provides high-touch, data-driven pharmacy care for medically complex and vulnerable populations, managing care for over 34 million lives across U.S. health plans as of 2026.

Products and services

  • RxAnte Core Analytics / RxAnte Score Patented predictive analytics platform that uses pharmacy and medical claims data to assess risk of unsafe medication use, predict future medication adherence at the member level, and generate risk scores to prioritize outreach. Sold to enterprise health plans, Medicaid plans, and value-based providers.
  • RxEffect Adherence Workflow Solution Clinical workflow and decision-support platform for pharmacists, care managers, and community-based providers that translates RxAnte's predictive analytics into configurable adherence workflows, weekly management reporting, and targeted patient-engagement program delivery. Sold to health plans and the providers serving their members.
  • Mosaic Pharmacy Service Technology-enabled, value-based pharmacy care management service delivered by RxAnte's wholly-owned subsidiary to medically complex and vulnerable Medicare populations, providing high-touch, data-driven in-home pharmacy care to reduce hospitalizations and total cost of care. Sold directly to enterprise health plans.

Quantifiable outcome

  • $406 PMPM savings; 32% reduction in inpatient stays
  • +6 more outcomes

Companies that use RxAnte

Customer profile

Named customers7 records

Segments5 records

Ideal customer profiles3 records

RxAnte technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

RxAnte partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered significant, minor and core.

  • Geisinger Health PlansignificantStrategic or Co-development Partner · 4 February 2019Partnership announced February 2019. RxAnte delivers population-level analytics and member-level decision support to inform Geisinger's pharmacy quality strategy, focusing on members' adherence to diabetes, hypertension, and high cholesterol medications.
  • CoalfireminorImplementation/ SI/ Consulting Partner · 4 February 2019Coalfire served as the HITRUST CSF Assessor conducting a thorough review of RxAnte's policies and practices during the HITRUST CSF certification process, focusing on oversight of the organization, vendor management programs, internal corporate governance, and risk management processes.
  • EnvisionInsurancesignificantStrategic or Co-development Partner · 19 July 2016Partnership continued July 2016. RxAnte uses data from large patient populations to predict individual patient adherence and develops customized interventions and outreach programs for each member, improving health outcomes and controlling costs for EnvisionInsurance's Part D members.
  • Horizon Healthcare Services, Inc.significantStrategic or Co-development Partner · 16 May 2016Renewed collaboration in May 2016. RxAnte provides advanced analytics solutions to predict future outcomes and manage prescription medication use for Horizon's Medicare Advantage population. Focus on triple-weighted Star Ratings medication adherence measures.
  • UPMC Health PlancoreStrategic or Co-development Partner · 1 January 2016UPMC Health Plan has been a partner since 2016, collaborating on peer-reviewed outcomes studies demonstrating Mosaic's effectiveness in improving health outcomes and reducing medical costs. UPMC also established a Center for Value-Based Purchasing for Pharmaceuticals in partnership with RxAnte. Brent Burns, EVP of UPMC Enterprises, stated Primus partnership will help accelerate bringing RxAnte solutions to more patients.
  • AvMedsignificantStrategic or Co-development Partner · 3 November 2015Partnership announced November 2015. RxAnte's advanced analytics platform delivered population-level reporting and member-level predictions to inform AvMed's adherence and intervention strategy for medications used to treat chronic illnesses for the Medicare Advantage Part D population.
  • Pharmacy Quality Alliance (PQA)significantStrategic or Co-development Partner · 1 January 2015RxAnte collaborated with PQA, Aetna, and WellCare to devise new performance measures to address opioid misuse/abuse. PQA endorsed these new opioid quality measures, which unsafe opioid use leads to nearly 100,000 ER visits annually.
  • WellCare Health PlanssignificantStrategic or Co-development Partner · 16 January 2014Agreement entered January 2014. RxAnte's advanced analytics platform used to identify existing Medicare members eligible for WellCare's Medication Therapy Management (MTM) services. WellCare has been providing MTM services since 2006 and working with RxAnte on medication quality measures since 2012.
  • AetnasignificantStrategic or Co-development Partner · 1 January 2013Innovative program launched in 2013 to engage providers in improving medication adherence for patients predicted to be at high risk. Co-hosted webinar between Aetna VP of Star Ratings and RxAnte senior leadership on pay-for-performance programs and medication adherence.

Scale indicators14 records

Recent moves6 records

Expansion highlights6 records

RxAnte competitors and assessment

Company assessment

Direct peers

  • AllazoHealth: AllazoHealth is an AI-driven medication adherence prediction platform serving health plans and PBMs. It is the closest functional peer to RxAnte, using predictive analytics on claims data to target adherence interventions for similar payer customers.
  • AdhereHealth: AdhereHealth provides medication adherence analytics and pharmacy care management services to Medicare Advantage, Medicaid, and commercial health plans. It overlaps directly with RxAnte's core analytics + intervention model and shares the same payer customer base.
  • OptimizeRx: OptimizeRx operates a digital therapeutics and adherence platform targeting prescribers and patients, with a network reaching the majority of US prescribers. It is comparable to RxAnte in addressing medication adherence through data-driven, point-of-care engagement with overlapping payer and pharma customers.
  • mPulse Mobile: mPulse Mobile delivers conversational AI-driven patient engagement programs for medication adherence, condition management, and health plan quality measures. It serves many of the same MA and Medicaid plans as RxAnte, executing the patient-engagement layer that RxAnte's RxEffect orchestrates.
  • Medisafe: Medisafe is a digital medication adherence platform combining a consumer app, predictive analytics, and payer integrations. It targets a similar problem space as RxAnte (medication non-adherence in chronic disease) but with more consumer-direct positioning, making it a partial-overlap peer.
  • emocha Health: emocha Health provides a medication adherence platform with directly observed therapy and asynchronous video verification, increasingly used by health plans for MTM and Star Ratings programs. It overlaps with RxAnte's clinical workflow and MTM focus areas.

Emerging players

  • Pack4U (Tabula Rasa HealthCare / CarelonRx): Pack4U delivers in-home and tech-enabled pharmacy services for complex patients, closely mirroring RxAnte's Mosaic Pharmacy Service value-based model. Both target medically complex Medicare populations with high-touch pharmacy care, though Pack4U is at an earlier commercial scale.

Broad incumbents

  • DrFirst: DrFirst provides ePrescribing, medication management, and clinical messaging across a large healthcare provider network. While broader in scope than RxAnte, its medication history, benefit, and adherence tooling overlaps with RxEffect and serves some of the same payer-provider ecosystem.
  • Surescripts: Surescripts operates the dominant US pharmacy electronic prescribing network and increasingly offers clinical and adherence-related intelligence to payers and providers. It is a broader infrastructure incumbent in the prescription data flow that RxAnte's analytics are built on.
  • CVS Health (Caremark): CVS Caremark is one of the largest US PBMs with in-house adherence analytics, MTM programs, and value-based pharmacy initiatives. While not a direct SaaS competitor, it represents the vertically integrated incumbent that may build or buy capabilities competitive with RxAnte.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

RxAnte social profiles

Digital presence

RxAnte compliance and trust

Trust signal

Compliance3 records

RxAnte financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RxAnte leadership team

Management profile

Number of profiles

Profiles6 records

RxAnte subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

RxAnte funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RxAnte M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RxAnte

What does RxAnte do?

RxAnte builds patented predictive analytics software (RxAnte Core Analytics/RxAnte Score, Value of Future Adherence) that uses pharmacy and medical claims data to forecast medication adherence and identify at-risk members. Its RxEffect workflow solution operationalizes these predictions for pharmacists, care managers, and providers, while the Mosaic Pharmacy Service subsidiary delivers in-home, value-based pharmacy care to medically complex Medicare beneficiaries. Customers are enterprise health plans, Medicaid plans, and value-based provider organizations.

Is RxAnte a public or private company?

RxAnte is a private company. It is classified as private equity controlled and is currently operating.

When was RxAnte founded?

RxAnte was founded in 2011. It employs 51 to 100 people.

Where is RxAnte based?

RxAnte is headquartered in Portland, United States, in the North America region.

How does RxAnte make money?

Four revenue lines are on record. Subscription Analytics Services are the primary driver. The others are value-Based Pharmacy Services (Mosaic Pharmacy Service), performance-Based Contracts and clinical Intervention Programs.

Who are RxAnte's main competitors?

Direct peers on record are AllazoHealth, AdhereHealth, OptimizeRx, mPulse Mobile, Medisafe and emocha Health. Pack4U (Tabula Rasa HealthCare / CarelonRx) is listed as an emerging player. Broad incumbents are DrFirst, Surescripts and CVS Health (Caremark).

Does RxAnte have an API?

No public API is recorded for RxAnte.

What industry is RxAnte in?

RxAnte's product category is Pharmacy Care Management Analytics. Its primary akta.pro industry code is HLAEAKAK, Pharmacy Benefit Analytics, Reporting & Employer Consulting, with a secondary code of HLAEAKAL, PBM Technology Platforms (ePA/eRx/Real-Time Benefit Tools). Its NAICS code is 5417 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
RxanteRxAnte Announces Investment from PrimusRxAnte, a Portland-based health technology company specializing in pharmacy care management analytics and services, announced a strategic growth investment from Primus Capital, a private equity firm focused on healthcare. The investment will accelerate RxAnte's expansion of value-based pharmacy solutions and its Mosaic Pharmacy Service subsidiary, which manages care for over 34 million lives across U.S. health plans as of 2026. UPMC Health Plan, a partner since 2016, collaborated on peer-reviewed outcomes studies demonstrating Mosaic's effectiveness in improving health outcomes and reducing medical costs.Pulse 2.0RxAnte Announces Strategic Growth Investment From Primus CapitalRxAnte, a pharmacy care management analytics and services provider, has secured a strategic growth investment from Primus Capital to scale its value-based pharmacy programs and expand clinical offerings through its Mosaic Pharmacy Service subsidiary. The company expects to manage more than 34 million lives in 2026 through partnerships with regional and national health plans, citing peer-reviewed outcomes studies with UPMC Health Plan demonstrating improved member health, reduced hospitalizations, and lowered medical costs. Primus Capital, which invests in healthcare technology and services companies, views RxAnte as a market leader in pharmacy care management and plans to support continued product innovation and expansion.FinSMEsRxAnte Raises Strategic Growth FundingRxAnte, a pharmacy care management provider, raised a strategic growth investment of undisclosed amount led by Primus Capital with UPMC Enterprises support. The funds will scale value-based pharmacy solutions and expand clinical services. The company manages over 34 million lives in 2026.citybizRxAnte Announces Strategic Growth Investment from Primus CapitalRxAnte announced a strategic growth investment from Primus Capital to support its expansion in pharmacy care management and clinical services for health plans. The investment aims to accelerate RxAnte’s efforts to scale its value-based solutions and expand its subsidiary Mosaic Pharmacy Service, which improves health outcomes and reduces medical costs.PR NewswireRxAnte Announces Strategic Growth Investment from Primus CapitalRxAnte, a pharmacy care management analytics and services company, announced a strategic growth investment from Primus Capital that will accelerate its value-based pharmacy solutions and expand clinical services for health plans. In 2026, the company will manage over 34 million lives in partnership with leading regional and national health plans. The investment supports rapid expansion of RxAnte's Mosaic Pharmacy Service subsidiary, which provides data-driven pharmacy care for medically complex and vulnerable populations.BuckeyehealthplanClinical Programs and Medication AdherenceBuckeye Health Plan has launched clinical programs and incentive structures to improve medication adherence among its members, partnering with Pharmacy Quality Solutions for the EQUIPP platform and RxAnte for the RxEffect tool. These initiatives provide pharmacies and providers with data-driven insights and financial bonuses for closing care gaps related to chronic conditions like diabetes and hypertension. The programs aim to optimize health outcomes while generating new revenue streams for healthcare providers through performance-based reimbursements.FinSMEsRxAnte Receives $25M Growth FinancingRxAnte, a pharmacy care management company based in Washington, D.C., secured $25 million in growth financing provided by Trinity Capital Inc. The firm has drawn $15 million from the facility with an option to draw an additional $10 million, intending to use the capital to expand its business reach and clinical programs.LinkedInTrinity Capital Inc. Provides $25 Million Growth Capital To RxAnte, Inc.RxAnte, Inc. announced the receipt of up to $25 million in growth capital from Trinity Capital to support its mission in providing analytics and value-based pharmacy services for health plans and at-risk providers. The funding aims to lower costs, improve care quality, and enhance member experience as they scale operations into 2023.SecSEC FORM DRxAnte, Inc. filed a Form D notice with the SEC on May 13, 2022 disclosing an exempt offering of pooled investment fund interests under Rule 506(b). The total offering amount was $10,900,000, with no sales commissions or finder's fees, and seven investors had already invested. The filing does not disclose the use of proceeds.